The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells
Aim. To perform the comparative study both of qualitative and quantitative content of lipids in parental and drug resistant breast cancer cells. Materials and methods. Parental (MCF-7/S) and resistant to cisplatin (MCF-7/CP) and doxorubicin (MCF-7/Dox) human breast cancer cells were used in the stud...
Saved in:
| Published in: | Experimental Oncology |
|---|---|
| Date: | 2012 |
| Main Authors: | Todor, I.N., Lukianova, N.Yu., Chekhun, V.F. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2012
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/138697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells / I.N. Todor, N.Yu. Lukianova, V.F. Chekhun // Experimental Oncology. — 2012. — Т. 34, № 2. — С. 97-100. — Бібліогр.: 28 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009)
by: Lukyanova, N.Yu., et al.
Published: (2009)
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011)
by: Rusetskaya, N.V., et al.
Published: (2011)
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009)
by: Rusetskaya, N.V., et al.
Published: (2009)
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010)
by: Lukyanova, N.Yu.
Published: (2010)
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)
by: Lukianova, N.Yu., et al.
Published: (2016)
Metabolic changes during development of Walker-256 carcinosarcoma resistance to doxorubicin
by: Todor, I.N., et al.
Published: (2015)
by: Todor, I.N., et al.
Published: (2015)
Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma
by: Burlaka, A.P., et al.
Published: (2015)
by: Burlaka, A.P., et al.
Published: (2015)
Hepcidin as a possible marker in determination of malignancy degree and sensitivity of breast cancer cells to cytostatic drugs
by: Yalovenko, T.M., et al.
Published: (2016)
by: Yalovenko, T.M., et al.
Published: (2016)
In vitro modification of cisplatin cytotoxicity with magnetic fluid
by: Chekhun, V.F., et al.
Published: (2013)
by: Chekhun, V.F., et al.
Published: (2013)
Lactoferrin expression in breast cancer in relation to biologic properties of tumors and clinical features of disease
by: Naleskina, L.A., et al.
Published: (2016)
by: Naleskina, L.A., et al.
Published: (2016)
Effect of 5-azacytidine on mirna expression in human breast cancer cells with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2016)
by: Chekhun, V.F., et al.
Published: (2016)
Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin
by: Chekhun, V.F., et al.
Published: (2014)
by: Chekhun, V.F., et al.
Published: (2014)
Morphological features of doxorubicin-resistant Walker 256 carcinosarcoma and response of mast cells
by: Boroday, N.V., et al.
Published: (2018)
by: Boroday, N.V., et al.
Published: (2018)
Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics
by: Chekhun, V.F., et al.
Published: (2017)
by: Chekhun, V.F., et al.
Published: (2017)
Modifying effects of lactoferrin in vitro on molecular phenotype of human breast cancer cells
by: Chekhun, V.F., et al.
Published: (2015)
by: Chekhun, V.F., et al.
Published: (2015)
Antitumor and antimetastatic activities of vaccine prepared from cisplatin-resistant lewis lung carcinoma
by: Potebnya, G.P., et al.
Published: (2009)
by: Potebnya, G.P., et al.
Published: (2009)
Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype
by: Chekhun, S., et al.
Published: (2013)
by: Chekhun, S., et al.
Published: (2013)
Influence of exogenous lactoferrin on the oxidant/ antioxidant balance and molecular profile of hormone receptor-positive and -negative human breast cancer cells in vitro
by: Zalutski, I.V., et al.
Published: (2017)
by: Zalutski, I.V., et al.
Published: (2017)
Significance of ferritin expression in formation of malignant phenotype of human breast cancer cells
by: Chekhun, S.V., et al.
Published: (2014)
by: Chekhun, S.V., et al.
Published: (2014)
Genetic polymorphisms of the renin-angiotensin system in breast cancer patients
by: Fishchuk, L.E., et al.
Published: (2013)
by: Fishchuk, L.E., et al.
Published: (2013)
СD44+/CD24− markers of cancer stem cells in patients with breast cancer of different molecular subtypes
by: Chekhun, S.V., et al.
Published: (2015)
by: Chekhun, S.V., et al.
Published: (2015)
Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells
by: Hussain, A., et al.
Published: (2014)
by: Hussain, A., et al.
Published: (2014)
Are CD44⁺/CD24⁻ cells the assumed cancer stem cells in breast cancer?
by: Ryspayeva, D.E., et al.
Published: (2017)
by: Ryspayeva, D.E., et al.
Published: (2017)
Characterization of the cytotoxic effects of the combination of cisplatin and flavanol (-)-epicatechin on human lung cancer cell line A549. An isobolographic approach
by: Varela-Castillo, O., et al.
Published: (2018)
by: Varela-Castillo, O., et al.
Published: (2018)
Relation between pathomorphological response in tumors after neoadjuvant chemotherapy and clinico-morphological and molecular prognostic factors in patients with breast cancer
by: Timovska, Yu.O., et al.
Published: (2009)
by: Timovska, Yu.O., et al.
Published: (2009)
Down-regulation of ABCC11 protein (MRP8) in human breast cancer
by: Sosonkina, N., et al.
Published: (2011)
by: Sosonkina, N., et al.
Published: (2011)
Dihydropyrimidine dehydrogenase activity correlates with fluorouracil sensitivity in breast cancer
by: Yu, Z., et al.
Published: (2007)
by: Yu, Z., et al.
Published: (2007)
Aspisol inhibits tumor growth and induces apoptosis in breast cancer
by: Zhu, X.G., et al.
Published: (2008)
by: Zhu, X.G., et al.
Published: (2008)
Clinicopathological features of nonspecific invasive breast cancer according to its molecular subtypes
by: Zavyalova, M., et al.
Published: (2016)
by: Zavyalova, M., et al.
Published: (2016)
Breast cancer immunohistochemical features in young women with BRCA1/2 mutations
by: Zakhartseva, L.M., et al.
Published: (2009)
by: Zakhartseva, L.M., et al.
Published: (2009)
Enterosorption as a method to decrease the systemic toxicity of cisplatin
by: Sakhno, L.A., et al.
Published: (2013)
by: Sakhno, L.A., et al.
Published: (2013)
Antitumor and genotoxic effects of lactoferrin in Walker-256 tumor-bearing rats
by: Chekhun, V.F., et al.
Published: (2018)
by: Chekhun, V.F., et al.
Published: (2018)
OX40L gene polymorphism and breast cancer in Iranian population
by: Vakil Monfared, R., et al.
Published: (2018)
by: Vakil Monfared, R., et al.
Published: (2018)
The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer
by: Ürün, Y., et al.
Published: (2015)
by: Ürün, Y., et al.
Published: (2015)
Cytogenetic effects of neutron therapy in patients with parotid gland tumors and relapse of breast cancer
by: Melnikov, A.A., et al.
Published: (2012)
by: Melnikov, A.A., et al.
Published: (2012)
Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells
by: Bezdenezhnykh, N., et al.
Published: (2014)
by: Bezdenezhnykh, N., et al.
Published: (2014)
Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU145 and LNCaP) in vitro
by: Zadvornyi, T.V., et al.
Published: (2018)
by: Zadvornyi, T.V., et al.
Published: (2018)
Clinical and immunohistochemical features of primary breast cancer and metachronous ovarian and endometrial tumors
by: Kryzhanivska, A.E., et al.
Published: (2018)
by: Kryzhanivska, A.E., et al.
Published: (2018)
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects
by: Berstein, L.M., et al.
Published: (2006)
by: Berstein, L.M., et al.
Published: (2006)
Lapatinib-based therapy for women with advanced/metastatic HER2 positive breast cancer
by: Zekri, J., et al.
Published: (2015)
by: Zekri, J., et al.
Published: (2015)
Similar Items
-
Molecular profile and cell cycle in mcf-7 cells resistant to cisplatin and doxorubicin
by: Lukyanova, N.Yu., et al.
Published: (2009) -
Distribution and accumulation of liposomal form of doxorubicin in breast cancer cells of MCF-7 line
by: Rusetskaya, N.V., et al.
Published: (2011) -
Molecular profile and cell cycle in MCF-7 and MCF‑7/Dox cells exposed to conventional and liposomal forms of doxorubicin
by: Rusetskaya, N.V., et al.
Published: (2009) -
Characteristics of homocysteine-induced multidrug resistance of human MCF-7 breast cancer cells and human A2780 ovarian cancer cells
by: Lukyanova, N.Yu.
Published: (2010) -
Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin
by: Lukianova, N.Yu., et al.
Published: (2016)